Back

Anticoagulation, atherosclerosis, and heart failure

European Heart Journal - Cardiovascular Pharmacotherapy

4 January 2017
Organised by: Logo
Read full article
ESC Journals

Contributors

Stefan Agewall
Stefan Agewall

Author

Karolinska Institute Stockholm , Sweden

You may be interested in
thumbnail
Congress Presentation
Anticoagulation with direct-acting anticoagulants decreases the risk of cardiovascular adverse events in patients with heart failure and atrial fibrillation compared to acenocoumarol
29 June 2021
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023
thumbnail
Congress Session
Navigating through heart failure device therapies
18 May 2025
thumbnail
Congress Session
Antithrombotic therapy for critically ill patients: focusing on anticoagulants
26 March 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources